Literature DB >> 23450999

Liver cirrhosis, transplantation and organ shortage.

Michael P Manns1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23450999      PMCID： PMC3583178          DOI： 10.3238/arztebl.2013.0083

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  9 in total

1.  The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.

Authors:  Tobias J Weismüller; Ahmed Negm; Thomas Becker; Hannelore Barg-Hock; Jürgen Klempnauer; Michael P Manns; Christian P Strassburg
Journal:  Transpl Int       Date:  2009-07-10       Impact factor: 3.782

Review 2.  HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents.

Authors:  Beatriz Calle Serrano; Michael P Manns
Journal:  Antivir Ther       Date:  2012-10-05

3.  Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

Authors:  Thierry Poynard; John McHutchison; Michael Manns; Christian Trepo; Karen Lindsay; Zachary Goodman; Mei-Hsiu Ling; Janice Albrecht
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

4.  [Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].

Authors:  H J Schlitt; M Loss; M N Scherer; T Becker; K-W Jauch; B Nashan; H Schmidt; U Settmacher; X Rogiers; P Neuhaus; C Strassburg
Journal:  Z Gastroenterol       Date:  2011-01-10       Impact factor: 2.000

5.  Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B.

Authors:  Eugene R Schiff; Samuel S Lee; You-Chen Chao; Seung Kew Yoon; Fernando Bessone; Shun-Sheng Wu; Wieslaw Kryczka; Yoav Lurie; Adrian Gadano; George Kitis; Suzanne Beebe; Dong Xu; Hong Tang; Uchenna Iloeje
Journal:  Clin Gastroenterol Hepatol       Date:  2010-12-08       Impact factor: 11.382

6.  Current standards in the treatment of chronic hepatitis C.

Authors:  Wolf Peter Hofmann; Christoph Sarrazin; Stefan Zeuzem
Journal:  Dtsch Arztebl Int       Date:  2012-05-11       Impact factor: 5.594

Review 7.  The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis.

Authors:  Johannes Wiegand; Thomas Berg
Journal:  Dtsch Arztebl Int       Date:  2013-02-08       Impact factor: 5.594

Review 8.  Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis.

Authors:  Andreas Pascher; Maxim Nebrig; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2013-03-08       Impact factor: 5.594

Review 9.  The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis.

Authors:  Tilman Sauerbruch; Beate Appenrodt; Volker Schmitz; Ulrich Spengler
Journal:  Dtsch Arztebl Int       Date:  2013-02-22       Impact factor: 5.594
  9 in total
  7 in total

Review 1.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

2.  Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation.

Authors:  Yinuo Li; Shosei Shimizu; Masashi Mizumoto; Takashi Iizumi; Haruko Numajiri; Hirokazu Makishima; Gong Li; Hideyuki Sakurai
Journal:  Cureus       Date:  2022-06-08

3.  Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.

Authors:  Sayan Mullick Chowdhury; Tzu-Yin Wang; Sunitha Bachawal; Rammohan Devulapally; Jung Woo Choe; Lotfi Abou Elkacem; Butrus Khuri Yakub; David S Wang; Lu Tian; Ramasamy Paulmurugan; Jürgen K Willmann
Journal:  J Control Release       Date:  2016-08-05       Impact factor: 9.776

Review 4.  [Management of decompensated liver cirrhosis in the intensive care unit].

Authors:  O Lerschmacher; A Koch; K Streetz; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-14       Impact factor: 0.840

5.  Effects of bone marrow-derived mesenchymal stem cells transplanted via the portal vein or tail vein on liver injury in rats with liver cirrhosis.

Authors:  Ying-Ming Song; Chang-Hong Lian; Cheng-Song Wu; Ai-Fang Ji; Juan-Juan Xiang; Xiao-Yan Wang
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

6.  Topical Application of Mesenchymal Stromal Cells Ameliorated Liver Parenchyma Damage After Ischemia-Reperfusion Injury in an Animal Model.

Authors:  Ping Kuen Lam; Charing Ching Ning Chong; Anthony Wing Ip Lo; Anthony Wing Hung Chan; Cindy See Wai Tong; Don Wai Ching Chin; Kenneth Hoi Kin Wong; Richard Kwong Wai Choy; Andrew Kai-Yip Fung; Yi Xiang Wang; Ka Fai To; Paul Bo San Lai
Journal:  Transplant Direct       Date:  2017-05-11

Review 7.  Decision modelling for economic evaluation of liver transplantation.

Authors:  Zhi Qu; Christian Krauth; Volker Eric Amelung; Alexander Kaltenborn; Jill Gwiasda; Lena Harries; Jan Beneke; Harald Schrem; Sebastian Liersch
Journal:  World J Hepatol       Date:  2018-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.